Deregulated microRNAs in myotonic dystrophy type 2

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Greco, Simona ^a   Perfetti, Alessandra ^a   Fasanaro, Pasquale ^c   Cardani, Rosanna ^a   Capogrossi, Maurizio C ^c   Meola, Giovanni ^a,b   Martelli, Fabio ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 125B 5P; MICRORNA 146B 5P; MICRORNA 193A 3P; MICRORNA 193B 3P; MICRORNA 208A; MICRORNA 221 3P; MICRORNA 34A 5P; MICRORNA 34B 3P; MICRORNA 34C 5P; MICRORNA 378A 3P; MICRORNA 381; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC IDENTIFICATION; GENETICS; HUMAN; HUMAN TISSUE; MALE; MYOTONIC DYSTROPHY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN RNA BINDING; RNA ANALYSIS; SKELETAL MUSCLE;

ATROPHY; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; HYPERTROPHY; MALE; MICRORNAS; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MYOTONIC DISORDERS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84863109517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039732     Document Type: Article

References (52)

1. Turner C, Hilton-Jones D, (2010) The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81: 358-367.
2. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, et al. (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60: 1854-1857.
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69: 385.
4. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, et al. (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258.
5. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, et al. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255: 1253-1255.
6. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, et al. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293: 864-867.
7. Wojciechowska M, Krzyzosiak WJ, (2011) Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 20: 3811-3821.
8. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
9. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
10. Mendell JT, (2005) MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184.
11. Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F, (2010) microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 125: 92-104.
12. Almeida MI, Reis RM, Calin GA, (2011) MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res 717: 1-8.
13. Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, et al. (2009) Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. Faseb J 23: 3335-3346.
14. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, et al. (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 104: 17016-17021.
15. Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, et al. (2011) miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep 12: 136-141.
16. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, et al. (2010) MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 12: 341-351.
17. Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, et al. (2010) Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med 8: 48.
18. Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, et al. (2011) Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord 21: 81-88.
19. Rau F, Freyermuth F, Fugier C, Villemin JP, Fischer MC, et al. (2011) Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol 18: 840-845.
20. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, et al. (2011) Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands. Neuromuscul Disord 21: 443-450.
21. Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G, (2004) Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48: 437-442.
22. Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, et al. (2010) Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol 119: 465-479.
23. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, et al. (2012) MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients. Diabetes.
24. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 57: 289-300.
26. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64.
27. Le Brigand K, Robbe-Sermesant K, Mari B, Barbry P, (2010) MiRonTop: mining microRNAs targets across large scale gene expression studies. Bioinformatics 26: 3131-3132.
28. Ge Y, Chen J, (2011) MicroRNAs in skeletal myogenesis. Cell Cycle 10: 441-448.
29. McCarthy JJ, Esser KA, Peterson CA, Dupont-Versteegden EE, (2009) Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 39: 219-226.
30. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, et al. (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662-673.
31. Erdreich LS, Lee ET, (1981) Use of relative operating characteristic analysis in epidemiology. A method for dealing with subjective judgement. Am J Epidemiol 114: 649-662.
32. Henderson AR, (1993) Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 30 (Pt 6): 521-539.
33. Hanley JA, McNeil BJ, (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
34. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, et al. (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60: 657-664.
35. Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, et al. (2004) Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 29: 275-281.
36. Chekulaeva M, Filipowicz W, (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21: 452-460.
37. Hermeking H, (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199.
38. Cardinali B, Castellani L, Fasanaro P, Basso A, Alema S, et al. (2009) Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells. PLoS One 4: e7607.
39. Ge Y, Sun Y, Chen J, (2011) IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol 192: 69-81.
40. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
41. Fardaei M, Larkin K, Brook JD, Hamshere MG, (2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res 29: 2766-2771.
42. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, et al. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11: 805-814.
43. Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, et al. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10: 2165-2170.
44. Serrano AL, Munoz-Canoves P, (2010) Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 316: 3050-3058.
45. Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, et al. (1995) Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 11: 1055-1060.
46. Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR, (1998) Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16: 2407-2411.
47. Rotwein P, Wilson EM, (2009) Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol 219: 503-511.
48. Harper PS, (2009) Myotonic dystrophy. Oxford; New York: Oxford University Press. xiii, 106 p. p.
49. Botta A, Vallo L, Rinaldi F, Bonifazi E, Amati F, et al. (2007) Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expr 13: 339-351.
50. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, et al. (2009) Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 18: 1471-1481.
51. Burge JA, Hanna MG, (2012) Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr Neurol Neurosci Rep 12: 62-69.
52. Toscano A, Messina S, Campo GM, Di Leo R, Musumeci O, et al. (2005) Oxidative stress in myotonic dystrophy type 1. Free Radic Res 39: 771-776.